CLINICAL_TRIALS
trial_result
· 2025-07-15
Clinical Trial Update: A Clinical Study of VA-CAG as Induction Therapy in Newly Diagnosed AML Patients [Phase 2]
Summary
A Phase 2 clinical trial evaluating VA-CAG as induction therapy for newly diagnosed acute myeloid leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hematology department of the 920th hospital | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED